Role of T cell metabolism in brain tumor development: a genetic and metabolic approach
Abstract Background Malignant brain tumors are among the most lethal cancers. Recent studies emphasized the crucial involvement of the immune system, especially T cells, in driving tumor progression and influencing patient outcomes. The emerging field of immunometabolism has shown that metabolic pat...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | BMC Neurology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12883-024-04015-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841544507280064512 |
|---|---|
| author | Bo Yang Zhenyu Li Peiliang Li Bo Liang Yuhan Liu Enshan Feng |
| author_facet | Bo Yang Zhenyu Li Peiliang Li Bo Liang Yuhan Liu Enshan Feng |
| author_sort | Bo Yang |
| collection | DOAJ |
| description | Abstract Background Malignant brain tumors are among the most lethal cancers. Recent studies emphasized the crucial involvement of the immune system, especially T cells, in driving tumor progression and influencing patient outcomes. The emerging field of immunometabolism has shown that metabolic pathways play a pivotal role in regulating immune responses within the tumor microenvironment. This study aims to clarify the relationships between specific T cell phenotypes, circulating metabolites, and malignant brain tumors. Methods We utilized a multiple mendelian randomization approach to investigate the associations between T cell phenotypes and malignant brain tumors, as well as the role of plasma metabolites in mediating these interactions. Instrumental variables were selected based on stringent criteria, and multiple mendelian randomization methods were utilized to identify causal pathways and metabolites potentially mediating these effects. Results Our analysis identified significant associations between seven distinct T cell phenotypes, including various CD8 + and regulatory T cell subsets, and the presence of malignant brain tumors. We also identified 87 plasma metabolites correlated with these tumors. Notably, metabolites such as octadecanedioylcarnitine (C18-DC) and eicosanedioate (C20-DC) were implicated in modulating the risk of developing malignant brain tumors. Furthermore, metabolites such as 5-dodecenoate (12:1n7) and arachidonate (20:4n6) were found to influence tumor risk, particularly in relation to CD28 − CD8 + T cells. Conclusion The study identifies key T cell phenotypes and plasma metabolites involved in the pathogenesis of malignant brain tumors, offering potential biomarkers and therapeutic targets for future interventions. |
| format | Article |
| id | doaj-art-4d437f39cae2453d8309d73c4028f2b8 |
| institution | Kabale University |
| issn | 1471-2377 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Neurology |
| spelling | doaj-art-4d437f39cae2453d8309d73c4028f2b82025-01-12T12:28:44ZengBMCBMC Neurology1471-23772025-01-012511810.1186/s12883-024-04015-1Role of T cell metabolism in brain tumor development: a genetic and metabolic approachBo Yang0Zhenyu Li1Peiliang Li2Bo Liang3Yuhan Liu4Enshan Feng5Department of Neurosurgery, Beijing Ditan Hospital, Capital Medical UniversityDepartment of Neonatology , The First Hospital of Jilin UniversityDepartment of Neurosurgery, Beijing Ditan Hospital, Capital Medical UniversityDepartment of Neurosurgery, Beijing Ditan Hospital, Capital Medical UniversityDepartment of Neurosurgery, Beijing Ditan Hospital, Capital Medical UniversityDepartment of Neurosurgery, Beijing Ditan Hospital, Capital Medical UniversityAbstract Background Malignant brain tumors are among the most lethal cancers. Recent studies emphasized the crucial involvement of the immune system, especially T cells, in driving tumor progression and influencing patient outcomes. The emerging field of immunometabolism has shown that metabolic pathways play a pivotal role in regulating immune responses within the tumor microenvironment. This study aims to clarify the relationships between specific T cell phenotypes, circulating metabolites, and malignant brain tumors. Methods We utilized a multiple mendelian randomization approach to investigate the associations between T cell phenotypes and malignant brain tumors, as well as the role of plasma metabolites in mediating these interactions. Instrumental variables were selected based on stringent criteria, and multiple mendelian randomization methods were utilized to identify causal pathways and metabolites potentially mediating these effects. Results Our analysis identified significant associations between seven distinct T cell phenotypes, including various CD8 + and regulatory T cell subsets, and the presence of malignant brain tumors. We also identified 87 plasma metabolites correlated with these tumors. Notably, metabolites such as octadecanedioylcarnitine (C18-DC) and eicosanedioate (C20-DC) were implicated in modulating the risk of developing malignant brain tumors. Furthermore, metabolites such as 5-dodecenoate (12:1n7) and arachidonate (20:4n6) were found to influence tumor risk, particularly in relation to CD28 − CD8 + T cells. Conclusion The study identifies key T cell phenotypes and plasma metabolites involved in the pathogenesis of malignant brain tumors, offering potential biomarkers and therapeutic targets for future interventions.https://doi.org/10.1186/s12883-024-04015-1Malignant brain tumorsT cellsPlasma metabolitesMendelian randomization |
| spellingShingle | Bo Yang Zhenyu Li Peiliang Li Bo Liang Yuhan Liu Enshan Feng Role of T cell metabolism in brain tumor development: a genetic and metabolic approach BMC Neurology Malignant brain tumors T cells Plasma metabolites Mendelian randomization |
| title | Role of T cell metabolism in brain tumor development: a genetic and metabolic approach |
| title_full | Role of T cell metabolism in brain tumor development: a genetic and metabolic approach |
| title_fullStr | Role of T cell metabolism in brain tumor development: a genetic and metabolic approach |
| title_full_unstemmed | Role of T cell metabolism in brain tumor development: a genetic and metabolic approach |
| title_short | Role of T cell metabolism in brain tumor development: a genetic and metabolic approach |
| title_sort | role of t cell metabolism in brain tumor development a genetic and metabolic approach |
| topic | Malignant brain tumors T cells Plasma metabolites Mendelian randomization |
| url | https://doi.org/10.1186/s12883-024-04015-1 |
| work_keys_str_mv | AT boyang roleoftcellmetabolisminbraintumordevelopmentageneticandmetabolicapproach AT zhenyuli roleoftcellmetabolisminbraintumordevelopmentageneticandmetabolicapproach AT peiliangli roleoftcellmetabolisminbraintumordevelopmentageneticandmetabolicapproach AT boliang roleoftcellmetabolisminbraintumordevelopmentageneticandmetabolicapproach AT yuhanliu roleoftcellmetabolisminbraintumordevelopmentageneticandmetabolicapproach AT enshanfeng roleoftcellmetabolisminbraintumordevelopmentageneticandmetabolicapproach |